Once the cash was drained from HemoBioTech, it ceased filing SEC reports. None were filed in 2011 and 2012.
One investor bet big on the firm in 2010. He was:
The author of a new soon to be released investment book, "Finding Midas" "The Way to Mega Stock Gains."
I hope the book came out before HemoBioTechs' breakdown.I'm sure this is the exception to Texas Tech's investing prowess. It was the only story available through the SEC. Count it as a one off.